Episode 14: Fine-Tuning Dual Antiplatelet Therapy in Atrial Fibrillation Post-PCI – Insights from the AUGUSTUS Trial
Update: 2024-11-10
Description
Summary
This study examines the effects of different antithrombotic treatments in patients with atrial fibrillation who have had an acute coronary syndrome or undergone percutaneous coronary intervention. The researchers specifically investigated whether the timing of treatment initiation, early versus late after the index event, influences the benefits and risks of dual antiplatelet therapy plus oral anticoagulation compared to a single P2Y12 inhibitor plus oral anticoagulation. The findings suggest that a short course of dual antiplatelet therapy might be beneficial early after the event, but this requires further investigation.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
